Residency · Residency · Vascular Surgery
Endoleak Classification and Post-EVAR Surveillance
Overview
An endoleak refers to the persistence of blood flow outside the lumen of the endograft but within the aneurysm sac. It represents the most common complication following endovascular aneurysm repair (EVAR) and is the primary reason for ongoing surveillance after the procedure. The presence of an endoleak maintains pressurization within the aneurysm sac, thereby sustaining the risk of rupture. However, not all endoleaks necessitate treatment; management decisions depend on the type of endoleak and its clinical significance.
Endoleak Classification
Type I: Seal Zone Leak
Type I endoleaks occur at the attachment sites of the endograft. Subtypes include Type Ia, which involves a proximal attachment site leak between the endograft and the aortic neck; Type Ib, a distal attachment site leak between the endograft limb and the iliac artery; and Type Ic, an iliac occluder leak seen in aortouniiliac configurations. These leaks are highly significant because they represent a direct communication between systemic arterial pressure and the aneurysm sac, leading to a high risk of sac expansion and rupture. Consequently, Type I endoleaks always require treatment. Common causes include a short or angulated neck, neck dilation over time, device migration, and undersizing of the graft.
Type II: Branch Vessel Leak
Type II endoleaks result from back-filling of the aneurysm sac through patent branch arteries. They are subdivided into Type IIa, involving a single branch vessel such as a lumbar artery or the inferior mesenteric artery (IMA), and Type IIb, involving two or more communicating branch vessels that provide both inflow and outflow. This is the most common type of endoleak, occurring in 10-25% of patients after EVAR. Typically, Type II endoleaks are benign and resolve spontaneously. Treatment is only indicated if the aneurysm sac expands by more than 5 mm. Persistent Type II endoleaks associated with sac growth occur in approximately 5-10% of cases.
Type III: Graft Defect
Type III endoleaks arise from defects in the graft itself. Type IIIa refers to junctional leaks between modular components, such as limb separation or disconnect, while Type IIIb involves fabric tears or holes in the graft material. These leaks are highly significant because they cause direct sac pressurization and therefore always require treatment. Although rare with modern devices, Type III endoleaks were more common with older graft designs.
Type IV: Graft Porosity
Type IV endoleaks are caused by diffusion of blood through an intact graft fabric, which appears as a blush on early post-deployment angiography. This phenomenon is self-limiting and resolves as coagulation normalizes. It is not clinically significant and does not require treatment. Essentially, Type IV endoleaks are a laboratory diagnosis and are rarely seen clinically with modern grafts.
Type V: Endotension
Type V endoleak, or endotension, is characterized by continued aneurysm sac expansion without any demonstrable endoleak on imaging studies. The underlying mechanisms are not well understood but may include undetectable microleaks, pressure transmission through thrombus, or ultrafiltration through the graft material. It remains a controversial entity and is considered a diagnosis of exclusion. Treatment options include re-lining the graft, open surgical conversion, or observation depending on the rate of sac growth.
| Type | Source | Frequency | Clinical Significance | Requires Treatment? |
|---|---|---|---|---|
| Ia | Proximal seal zone | 2–5% | High (systemic pressure in sac) | Always |
| Ib | Distal seal zone | 1–3% | High (systemic pressure in sac) | Always |
| II | Branch vessels (lumbar, IMA) | 10–25% | Usually low; benign if sac stable | Only if sac expands >5 mm |
| IIIa | Modular component junction | Rare | High (direct sac pressurization) | Always |
| IIIb | Fabric tear/hole | Rare | High (direct sac pressurization) | Always |
| IV | Graft porosity | Rare (modern grafts) | None (self-limiting) | No |
| V | Endotension (no visible leak) | Rare | Variable (sac expansion without leak) | If progressive sac growth |
<image>Diagram illustrating all five types of endoleak after EVAR with a cross-sectional view of the aorta and endograft, showing the pathways of blood flow for Type I (proximal and distal seal zone), Type II (lumbar and IMA branches), Type III (component separation and fabric tear), Type IV (graft porosity), and Type V (endotension with no visible leak)</image>
Post-EVAR Surveillance Protocols
Standard Protocol (SVS/ESVS Guidelines)
The standard surveillance protocol following EVAR, as recommended by the Society for Vascular Surgery (SVS) and the European Society for Vascular Surgery (ESVS), includes a baseline computed tomography angiography (CTA) within 30 days of the procedure. A follow-up CTA is performed at 12 months, followed by annual imaging thereafter. Subsequent surveillance may utilize CTA or duplex ultrasound if the initial CT scans demonstrate stability.
Surveillance Modalities
CT Angiography (CTA)
CTA remains the gold standard for detecting endoleaks and measuring aneurysm sac size. A multiphase protocol is employed, consisting of a non-contrast phase to establish baseline sac size and detect calcification, an arterial phase to identify Type I and III endoleaks and assess graft patency, and a delayed phase (60-90 seconds) to detect Type II endoleaks. Despite its diagnostic accuracy, CTA has limitations including radiation exposure, risk of contrast-induced nephropathy, and higher cost.
Duplex Ultrasound
Duplex ultrasound can measure sac diameter and detect endoleaks by identifying color flow within the sac. Although it is less sensitive than CTA for detecting Type II endoleaks, it offers advantages such as the absence of radiation and contrast use, lower cost, and portability. However, its accuracy is operator-dependent and can be limited by patient body habitus. Duplex ultrasound may be used as the primary surveillance modality in stable patients without endoleaks and with stable or shrinking sac size.
Contrast-Enhanced Ultrasound (CEUS)
Contrast-enhanced ultrasound utilizes microbubble contrast agents such as SonoVue or Lumason to improve endoleak detection. Its sensitivity approaches that of CTA for detecting Type II endoleaks. CEUS has no nephrotoxicity and does not involve radiation exposure, making it an increasingly valuable alternative to CTA, especially in patients with renal insufficiency.
Magnetic Resonance Angiography (MRA)
MRA is useful in patients with renal insufficiency or contrast allergy, particularly when non-contrast techniques are employed. However, its utility is limited by artifacts caused by certain graft materials, and it is not widely used for routine surveillance.
Plain Abdominal Radiograph (KUB)
Plain abdominal radiographs can detect stent graft migration, limb kinking, and stent fracture. They are low cost and do not require contrast administration. While they supplement cross-sectional imaging, they do not replace it.
Sac Behavior as a Surveillance Endpoint
The behavior of the aneurysm sac is a critical endpoint in surveillance. Sac shrinkage is a favorable sign indicating complete exclusion of the aneurysm. A stable sac is acceptable and warrants continued surveillance. Sac expansion greater than 5 mm is concerning and should prompt a search for an endoleak and consideration of intervention. Notably, sac expansion can occur even without a visible endoleak, as in cases of endotension.
<image>Post-EVAR CT angiography images in arterial and delayed phases showing a Type II endoleak from a patent lumbar artery, with contrast opacification of the aneurysm sac visible on the delayed phase but not the arterial phase, with sac diameter measurements annotated</image>
Management of Endoleaks
Type I Endoleak
Type I endoleaks always require treatment due to their high risk of rupture. For proximal (Type Ia) leaks, initial management involves ballooning of the proximal seal zone. If this is unsuccessful, placement of a proximal extension cuff, such as a Palmaz stent or aortic extension, may be performed. Endoanchors like HeliFX can be used to secure the graft to the aortic wall. Embolization of the perigraft channel is another option. Open surgical conversion is reserved for cases where endovascular approaches fail. For distal (Type Ib) leaks, limb extension into the iliac artery is typically performed. If there is no adequate common iliac landing zone, extension into the external iliac artery with hypogastric embolization or use of an iliac branch device may be necessary.
Type II Endoleak
Type II endoleaks are managed conservatively with observation if the aneurysm sac is stable or shrinking. Intervention is indicated if the sac expands by more than 5 mm on serial imaging. Treatment options include transarterial embolization, often via a superior mesenteric artery to inferior mesenteric artery approach for IMA-related leaks, or translumbar embolization involving direct sac puncture under CT guidance with coil and glue embolization. Transcaval embolization, an emerging technique, involves an endovascular approach through the inferior vena cava into the sac. Laparoscopic ligation of the IMA or lumbar arteries and open sac excision are reserved for refractory cases. Recurrence after embolization is common, occurring in up to 40% of cases, and may require repeat treatment.
Type III Endoleak
Type III endoleaks also always require treatment due to their high risk. Management involves relining the graft with an additional endograft component to cover the defect. If the leak is due to junctional separation, a bridging stent graft is placed. Open surgical conversion is considered if endovascular repair is not feasible.
Type V (Endotension)
For Type V endoleak with progressive sac growth, treatment options include re-lining the graft, open conversion, or sac fenestration. There is no consensus on optimal management for endotension.
Reducing Surveillance Burden
There is ongoing debate about whether surveillance frequency can be safely reduced in certain patients. Those considered low-risk—characterized by a stable sac and absence of endoleak over 1 to 5 years—may be candidates for less frequent surveillance using ultrasound alone. The ESVS guidelines suggest considering ultrasound-based surveillance after five years of stability. However, late device failure, such as Type III endoleak or graft migration, can still occur, so surveillance should never be completely discontinued.
Device Migration
Device migration is defined as a caudal movement greater than 10 mm from the initial deployment position. Risk factors include a short or angulated neck, a large diameter neck, and absence of suprarenal fixation. Migration can cause a Type Ia endoleak and may necessitate proximal extension, placement of endoanchors, or open surgical conversion.
Post-EVAR Rupture
The annual rupture rate after EVAR is approximately 0.5-1%. Rupture can occur with or without an identifiable endoleak and is associated with Type I or III endoleaks, sac expansion, and late graft failure. Emergency management involves endovascular repair if possible, or open conversion if not. Mortality from post-EVAR rupture is lower than that from de novo rupture, approximately 20-30%, because the aneurysm sac is partially contained.
Clinical Pearls
Type I and III endoleaks represent high-pressure, high-risk leaks that always require treatment. In contrast, Type II endoleaks are the most common but usually benign and should only be treated if the aneurysm sac is enlarging. Completion angiography at the time of EVAR must be carefully scrutinized for Type I endoleaks; the operating room should never be left with a Type I leak present. The most important surveillance parameter is sac behavior, with sac shrinkage being the best indicator of successful aneurysm exclusion. Patients must understand that EVAR requires lifelong surveillance. Contrast-enhanced ultrasound is an underutilized modality that can reduce the burden of CT imaging. Finally, late device failure is a real concern, so the "set it and forget it" approach does not apply to EVAR.
References
- White GH, et al. Endoleak as a complication of endoluminal grafting. J Endovasc Surg. 1997;4(2):152-168.
- Chaikof EL, et al. SVS practice guidelines on AAA. J Vasc Surg. 2018;67(1):2-77.
- Wanhainen A, et al. ESVS 2019 Guidelines on Abdominal Aorto-iliac Artery Aneurysms. Eur J Vasc Endovasc Surg. 2019;57(1):8-93.
- Sidloff DA, et al. Type II endoleak after EVAR. Br J Surg. 2013;100(10):1262-1270.
- Mirza TA, et al. Contrast-enhanced ultrasound for endoleak detection after EVAR. Eur J Vasc Endovasc Surg. 2010;39(5):559-564.
